Skip to main content

Publications

Click here for Google Scholar author search

Publications

Book, Chapter or Section

Hill JT. 2019. Identifying toxicant-interacting genes using forward-genetic screening in zebrafish. Jason Hansen, Louise Winn, editors. Developmental Toxicology: Methods and Protocols, Second Edition. Jason Hansen, Louise Winn, editors. New York, NY: Springer.

Journal Article, Academic Journal

McGuire KL, Smit P, Ess DH, Hill JT, Harrison RG, Busath DD. 2021. Mechanism and Kinetics of Copper Complexes Binding to the Influenza A M2 S31N and S31N/G34E Channels. 120(1):168-177.

McGuire KL, Hill JT, Busath DD. 2020. Increased Dissociation of Adamantanamines in Influenza A M2 S31N with Partial Block by Rimantadine. 119(9):1811-1820.

Chen T, Hill JT, Moore TM, ECK C, Olsen ZE, Piorczynski TB, Marriott TD, Tessem JS, Walton CM, Bikman BT, et al. 2020. Lack of skeletal muscle liver kinase B1 alters gene expression, mitochondrial content, inflammation and oxidative stress without affecting high-fat diet-induced obesity or insulin resistance. 1866(8):165805.

Domyan ET, Hardy J, Wright T, Frazer C, Daniels J, Kirkpatrick J, Hill JT. 2019. SOX10 regulates multiple genes to direct eumelanin versus pheomelanin production in domestic rock pigeon. 32(5):634-642.

Fox J, Evans AT, Blomfield MP, Livingstone SK, Tenney SR, Webster JB, Perry K, Hill JT, Bikman BT, MDH H. 2019. Resistance mechanisms and cross-resistance for a pyridine-pyrimidine amide inhibitor of microtubule polymerization. 29(13):1647-1653.

Fox JC, Evans AT, Blomfield MP, Livingstone SK, Tenney SR, Webster JB, Perry K, Hill JT, Bikman BT, Hansen MD. 2019. Resistance mechanisms and cross-resistance for a pyridine-pyrimidine amide inhibitor of microtubule polymerization. 29(13):1647-1653.

Johnson SP, Yates JD, Frederich ZB, Hill JT. 2018. ZeMo: An Open Source Water Quality Monitoring System for Aquaria. 15(6):652-655.

Hill JT, Demarest B, Gorsi B, Smith M, Yost HJ. 2017. Heart morphogenesis gene regulatory networks revealed by temporal expression analysis. 144(19):3487--3498. [Website]

Karanth S, Zinkhan EK, Hill JT, Yost HJ, Schlegel A. 2016. FOXN3 Regulates Hepatic Glucose Utilization. 15(12):2745-55.

Ray JD, Kener KB, Bitner BF, Wright BJ, Ballard MB, Barrett EJ, Hill JT, Moss LG, Tessem JS. 2016. Nkx61-mediated insulin secretion and β-cell proliferation is dependent on upregulation of c-Fos. 590(12):1791-803.

Hill JT, Demarest BL, Bisgrove BW, Su YC, Smith M, Yost HJ. 2014. Poly peak parser: Method and software for identification of unknown indels using sanger sequencing of polymerase chain reaction products. 243(12):1632-6.

Sarkar AA, Nuwayhid SJ, Maynard T, Ghandchi F, Hill JT, Lamantia AS, Zohn IE. 2014. Hectd1 is required for development of the junctional zone of the placenta. 392(2):368-80.

Hill JT, Demarest BL, Bisgrove BW, Gorsi B, Su YC, Yost HJ. 2013. MMAPPR: mutation mapping analysis pipeline for pooled RNA-seq. 23(4):687-97.

Maguire CT, Demarest BL, Hill JT, Palmer JD, Brothman AR, Yost HJ, Condic ML. 2013. Genome-wide analysis reveals the unique stem cell identity of human amniocytes. 8(1):e53372.

Arnes L, Hill JT, Gross S, Magnuson MA, Sussel L. 2012. Ghrelin expression in the mouse pancreas defines a unique multipotent progenitor population. 7(12):e52026.

Hill JT, Anderson KR, Mastracci TL, Kaestner KH, Sussel L. 2011. Novel computational analysis of protein binding array data identifies direct targets of Nkx22 in the pancreas. 12:62.

Hill JT, Chao CS, Anderson KR, Kaufman F, Johnson CW, Sussel L. 2010. Nkx22 activates the ghrelin promoter in pancreatic islet cells. 24(2):381-90.

Hill JT, Mastracci TL, Vinton C, Doyle ML, Anderson KR, Loomis ZL, Schrunk JM, Minic AD, Prabakar KR, Pugliese A, et al. 2009. Ghrelin is dispensable for embryonic pancreatic islet development and differentiation. 157(1-3):51-6.

Journal Contribution, Nonfiction

Speirs MM, Swensen AC, Chan TY, Jones PM, Holman JC, Harris MB, Maschek JA, Cox JE, Carson RH, Hill JT, et al. 2019. Imbalanced sphingolipid signaling is maintained as a core proponent of a cancerous phenotype in spite of metabolic pressure and epigenetic drift. Oncotarget. 32.